Common Contracts
1 similar Master Agency Agreement contracts
DAWNRAYS PHARMACEUTICAL (HOLDINGS) LIMITEDMaster Agency Agreement • July 15th, 2016
This announcement is made by Dawnrays Pharmaceutical (Holdings) Limited (the “Company”) to provide its shareholders and potential investors with updated information in relation to the sales of 0.5mg “Leiyide” ( 雷易得) (Entecavir Dispersible Tablets) (“Leiyide” or the “Product”) manufactured by the Company’s subsidiary Suzhou Dawnrays Pharmaceutical Co., Ltd. (“Suzhou Dawnrays”) (collectively referred to as the “Group”).
